Rizwan Daudi
About Rizwan Daudi
Rizwan Daudi is a Senior Clinical Trials Manager at Kite Pharma, where he has worked since 2021. He has a background in Pharmaceutical Sciences and extensive experience in clinical research, including roles at Syneos Health Clinical Solutions and Kite Pharma.
Work at Kite Pharma
Rizwan Daudi currently serves as a Senior Clinical Trials Manager at Kite Pharma, a position he has held since 2021. In this role, he is responsible for overseeing clinical trials and ensuring compliance with regulatory requirements. Previously, he worked as a Clinical Trials Manager at Kite Pharma from 2019 to 2021. His experience at Kite Pharma includes leading a multi-centre global project in clinical operations, which involves coordinating efforts across various sites to ensure the successful execution of clinical studies.
Previous Experience at Syneos Health
Before joining Kite Pharma, Rizwan Daudi worked at Syneos Health Clinical Solutions, previously known as INC Research/inVentiv Health, from 2012 to 2019. During his tenure as Clinical Operations Lead, he managed clinical trials and contributed to the operational aspects of clinical research. His experience at Syneos Health provided him with a strong foundation in clinical operations and project management within the pharmaceutical industry.
Education and Expertise
Rizwan Daudi studied at the University of Hertfordshire, where he earned a Bachelor of Science (BSc) degree in Pharmaceutical Sciences from 1999 to 2002. His educational background has equipped him with a solid understanding of pharmaceutical principles and practices, which he applies in his current role in clinical trials management. He has over six years of onsite monitoring experience in clinical research, further enhancing his expertise in the field.
Interest in Clinical Research in the Middle East
Rizwan Daudi has expressed a keen interest in working in the clinical research sector in the Middle East. This interest reflects his desire to expand his professional horizons and contribute to the growth of clinical research in emerging markets. His background in clinical trials management positions him well to engage in opportunities within this region.